Exact Sciences logo

EXAS - Exact Sciences News Story

$93.38 -3.4  -3.5%

Last Trade - 5:16pm

Sector
Healthcare
Size
Large Cap
Market Cap £11.77bn
Enterprise Value £11.62bn
Revenue £1.06bn
Position in Universe 674th / 6846

BUZZ-Exact Sciences acquires DNA sequencing lab, shares rise

Wed 14th April, 2021 2:34pm
** Shares of molecular diagnostics company  EXAS.O  rise
1.6% to $130 premarket
    ** Co says it has completed acquisition of DNA sequencing
lab Ashion Analytics from Arizona-based Translational Genomics
Research Institute (TGen) (https://refini.tv/3e5rccC)
    ** TGen is an affiliate of City of Hope, an independent
biomedical research and treatment center for cancer, diabetes
and other life-threatening diseases
    ** On Feb. 16, EXAS entered into an agreement with
Translational Genomics Research Institute to acquire Ashion
    ** EXAS also enters into a 10-year research collaboration
with TGen, according to the agreement
    ** XMS Capital served as financial adviser to Exact
Sciences, while Citi served as financial adviser to TGen and
City of Hope
    ** EXAS stock down ~3% this year, as of last close
    

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.